Thank you for your interest in the Applying Pharmacology to Drug Discovery course with Dr. objective of this course is to give the registrant a good overall understanding of the unique science of pharmacology Pharmacology is a unique discipline and is critical to drug discovery. Registrants will learn: 1. What makes each drug type unique to therapeutic pharmacology? 3. Modules: Week 1 - Fundamentals of Pharmacology Week 2 - Characterizing Agonists Week 3 - Characterizing

Main objectives: - Learning how to perform advanced GPCR pharmacology data analysis in support of drug - Understanding the pharmacology data analysis framework we use for GPCRs. The participants will increase their ability to perform, understand, and communicate GPCR pharmacology Module 1 - Concentration-response analysis: Become a CRC super-user Module 2 - Quantifying agonist pharmacology and biased agonism Module 3 - Antagonist pharmacology and binding assay analysis Module 4 - New dimensions

appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological Society. "ASCEPT is the peak professional society devoted to advancing excellence in Clinical and Experimental “I am honoured to be appointed President of ASCEPT, and am particularly excited given the Society’s conference

October 2022 Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment The network pharmacology method was used to constructe the "herb-component-target" network, and elucidated

This study demonstrated the pharmacological properties and functions of PxOctβ3 in P. xylostella, thus

He has a degree and PhD in pharmacology from Queens' College, Cambridge and University College London , respectively, was the youngest person to be elected as a Fellow of the British Pharmacological Society in 2012, and was the recipient of the British Pharmacological Society Novartis Prize in 2017. Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience , ACS Pharmacology & Translational Science and Frontiers in Pharmacology.

The focus of his research is the molecular pharmacology of cannabinoids and cannabinoid receptors. He was the 2018 and 2021 recipient of the Young Investigator of the Year Awards from the British Pharmacological Society and International Cannabinoid Research Society (ICRS), respectively.

ranks at Warwick to become an Associate Professor before leaving in 2015 to join the Department of Pharmacology In 2020, he was promoted to a Readership/Professor in Receptor Pharmacology and was elected a Fellow of the British Pharmacological Society. His research group uses a combination of pharmacological investigations and mathematical modeling to industry (GSK, Takada, and Firmenich) which have recently been enhanced through him being awarded a Royal Society